3/6/2009

Indian drugmaker Wockhardt is considering selling its biotech unit, and Pfizer and Sanofi-Aventis expressed interest in purchasing a significant stake in the subsidiary, according to a person familiar with the matter. Pfizer and Sanofi-Aventis wrote in separate statements that they do not comment on market rumors.

Related Summaries